Jean-Arthur Micoulaud-Franchi
Jean-Arthur Micoulaud-Franchi
CNRS USR Sanpsy
Verified email at chu-bordeaux.fr
TitleCited byYear
Medical and mental disorder: Proposed definition and criteria
RL Spitzer, J Endicott, JAM Franchi
Annales Médico-psychologiques, revue psychiatrique 176 (7), 656-665, 2018
2132018
Ketamine administration in depressive disorders: a systematic review and meta-analysis
G Fond, A Loundou, C Rabu, A Macgregor, C Lançon, M Brittner, ...
Psychopharmacology 231 (18), 3663-3676, 2014
1972014
EEG neurofeedback treatments in children with ADHD: an updated meta-analysis of randomized controlled trials
JA Micoulaud-Franchi, PA Geoffroy, G Fond, R Lopez, S Bioulac, P Philip
Frontiers in human neuroscience 8, 906, 2014
1212014
Resting cortical PET metabolic changes in psychogenic non-epileptic seizures (PNES)
M Arthuis, JA Micoulaud-Franchi, F Bartolomei, A McGonigal, E Guedj
J Neurol Neurosurg Psychiatry 86 (10), 1106-1112, 2015
562015
Electroencephalographic neurofeedback: Level of evidence in mental and brain disorders and suggestions for good clinical practice
JA Micoulaud-Franchi, A Mcgonigal, R Lopez, C Daudet, I Kotwas, ...
Neurophysiologie Clinique/Clinical Neurophysiology 45 (6), 423-433, 2015
482015
Risk of motor vehicle accidents related to sleepiness at the wheel: a systematic review and meta-analysis
S Bioulac, JAM Franchi, M Arnaud, P Sagaspe, N Moore, F Salvo, P Philip
Sleep 40 (10), 2017
412017
Rapid detection of generalized anxiety disorder and major depression in epilepsy: validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample
JA Micoulaud-Franchi, S Lagarde, G Barkate, B Dufournet, C Besancon, ...
Epilepsy & Behavior 57, 211-216, 2016
352016
One step closer to a global tool for rapid screening of major depression in epilepsy: validation of the French NDDI-E
JA Micoulaud-Franchi, G Barkate, A Trébuchon-Da Fonseca, L Vaugier, ...
Epilepsy & Behavior 44, 11-16, 2015
342015
Neurofeedback: One of today's techniques in psychiatry?
M Arns, JM Batail, S Bioulac, M Congedo, C Daudet, D Drapier, T Fovet, ...
L'Encéphale 43 (2), 135-145, 2017
332017
Skin conductance biofeedback training in adults with drug-resistant temporal lobe epilepsy and stress-triggered seizures: a proof-of-concept study
JA Micoulaud-Franchi, I Kotwas, L Lanteaume, C Berthet, M Bastien, ...
Epilepsy & Behavior 41, 244-250, 2014
332014
Parieto-temporal alpha EEG band power at baseline as a predictor of antidepressant treatment response with repetitive transcranial magnetic stimulation: a preliminary study
JA Micoulaud-Franchi, R Richieri, M Cermolacce, A Loundou, C Lancon, ...
Journal of affective disorders 137 (1-3), 156-160, 2012
332012
Melatonin and melatonin agonists as adjunctive treatments in bipolar disorders
P Alexis Geoffroy, B Etain, JA Micoulaud Franchi, F Bellivier, P Ritter
Current pharmaceutical design 21 (23), 3352-3358, 2015
292015
A preliminary study on cognitive enhancer consumption behaviors and motives of French Medicine and Pharmacology students
JA Micoulaud-Franchi, A MacGregor, G Fond
Eur Rev Med Pharmacol Sci 18 (13), 1875-8, 2014
292014
The bidirectional relation between emotional reactivity and sleep: From disruption to recovery.
E Altena, JA Micoulaud-Franchi, PA Geoffroy, E Sanz-Arigita, S Bioulac, ...
Behavioral neuroscience 130 (3), 336, 2016
282016
D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive-compulsive disorders: a metaregression analysis
D Ducasse, L Boyer, P Michel, A Loundou, A Macgregor, ...
Psychopharmacology 231 (18), 3765-3770, 2014
282014
(Mis) use of prescribed stimulants in the medical student community: motives and behaviors: a population-based cross-sectional study
G Fond, M Gavaret, C Vidal, L Brunel, JP Riveline, JA Micoulaud-Franchi, ...
Medicine 95 (16), 2016
272016
Innovative mechanisms of action for pharmaceutical cognitive enhancement: a systematic review
G Fond, JA Micoulaud-Franchi, L Brunel, A Macgregor, S Miot, R Lopez, ...
Psychiatry research 229 (1-2), 12-20, 2015
242015
Do schizophrenia patients with low P50-suppression report more perceptual anomalies with the sensory gating inventory?
JA Micoulaud-Franchi, WP Hetrick, M Aramaki, A Bolbecker, L Boyer, ...
Schizophrenia research 157 (1-3), 157-162, 2014
242014
Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set
G Fond, O Godin, L Brunel, B Aouizerate, F Berna, E Bulzacka, ...
Journal of affective disorders 191, 209-215, 2016
232016
Quality of life is associated with chronic inflammation in schizophrenia: a cross-sectional study
M Faugere, JA Micoulaud-Franchi, M Alessandrini, R Richieri, ...
Scientific reports 5, 10793, 2015
232015
The system can't perform the operation now. Try again later.
Articles 1–20